Your sneak peek at the next buzzy biotech
Meet VL49, a code-named biotech startup operating in stealth with money from the industry's most bombastic venture firm and plans to put some buzzy technologies to use.
STAT's Kate Sheridan has the details on the company, which is graduating from a shared lab space and plans to triple its workforce by 2020. Flagship Pioneering, the firm that brought you Moderna Therapeutics and Rubius Therapeutics, is funding the fledgling company, which promises to use artificial intelligence in its efforts to craft new medicines.
Read more.
No hay comentarios:
Publicar un comentario